We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Thyroid Tests Overused During Psychiatric Admissions

By HospiMedica International staff writers
Posted on 22 Dec 2011
A new study suggests that screening for thyroid-stimulating hormone (TSH) is done both too often and unnecessarily when patients are admitted for psychiatric evaluation.

Researchers at Waterbury Hospital (Waterbury, CT, USA) conducted a chart review for 98 patients (83% of whom had a previous psychiatric history) to examine the appropriateness of measuring TSH levels in patients under evaluation because of behavioral disturbances, even if there are no other clinical signs or symptoms suggesting thyroid dysfunction. More...
In all, TSH screening was ordered for 66.3% of the adult patients admitted to an inpatient psychiatry unit during one eight-week period.

The results showed that 97% of those tests turned out to be within the normal range, with only two patients whose TSH levels were outside the normal range, of whom one was elevated and one was low. When the admission diagnoses among patients who had undergone TSH screening and those who had not were considered, depression was identified in 26 and 7 patients, respectively. There was no difference in the length of hospital stay in the TSH group and the non-TSH group, with a mean stay of 9.5 days. Nine patients in the TSH group and eight in the non-TSH group had also undergone screening within the previous six months. The study was presented as a poster session at the midyear clinical meeting of the American Society of Health-System Pharmacists (ASHP), held during December 2011 in New Orleans (LA, USA).

“Routine TSH screening should not be done for patients with a long history of psychiatric disease, as was the case in most of our patients, and especially if a previous level has been obtained recently,” said lead author and study presenter Kelly Shepard, PharmD. “We have many patients with frequent readmissions. The test can be useful for patients with a first admission, but is unnecessary in patients with a 10-year history of disease.”

Both hyper- and hypothyroidism are recognized as potential contributors to psychiatric illness, with psychosis being specifically included in the diagnostic criteria for thyroid storm. In addition, the US Endocrine Society (Chevy Chase, MD, USA) guidelines state that thyrotoxicosis, with a TSH level below 0.01 mU/L, can cause alterations in psychiatric and neuropsychological function. Depression also has been linked with thyroid dysfunction, particularly among patients with previously recognized thyroid abnormalities.

Related Links:
Waterbury Hospital
US Endocrine Society


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.